OM:MCAPLife Sciences
MedCap (OM:MCAP) Margin Decline Raises Questions Despite Strong Revenue Growth Forecasts
MedCap (OM:MCAP) delivered revenue growth forecasts of 13.2% per year, putting the broader Swedish market’s 3.8% annual pace in the shade. While the company’s net profit margin sits at 10% compared to last year’s 12.7%, the last five years saw average annual earnings growth of 25.9%, though the most recent year recorded a negative figure. For investors, robust long-term earnings growth, an ongoing top-line trajectory, and a share price that trades below intrinsic value estimates will likely...